FLT4 and Milroy disease: Therefore, the VEGFR3 activity is affected and downstreamVEGFR3 signaling pathways are disrupted, which is expected to lead to a lymphatic phenotype if the effect is comparable to that of Milroy disease associated VEGFR3 mutations.